MENU
BLTE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Belite Bio (BLTE) Ownership - Who owns Belite Bio?

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout... Show more

Profile

Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
20
Web
https://www.belitebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.27B
P/E Ratio
N/A
Total Cash
145.15M
Projected Growth
N/A
Total Debt
537K
Revenue
N/A
Risk (Beta)
-0.35
Dividend Yield
N/A
Total Cash/Share
4.46
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BLTE
Capitalization
2.27B
P/E Ratio
N/A
Risk (Beta)
-0.35
Dividend Yield
N/A
Total Cash
145M
Total Cash/Share
4.46
Total Debt
537K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
158M
P/B Ratio
14.39
Cash Flow
N/A
Earnings
-1.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
24.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-43.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.07
Shares Held By Institutions
12M
Shares Outstanding - Current
32.5M
Total Liabilities
6.13M
Total Volume MTD
N/A
Value
-1
Gain YTD
10.745
View a ticker or compare two or three
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BLTE showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
20
Web
https://www.belitebio.com